Company Filing History:
Years Active: 2016
Title: Helene Skjøt-Arkil: Innovating Pathology Diagnostics
Introduction
Helene Skjøt-Arkil, a prominent inventor based in Copenhagen, Denmark, has made significant contributions to the field of medical diagnostics. With a focus on pathology biomarkers, her innovative approach aids in the diagnosis and quantitation of various pathological conditions, showcasing her role as a leading figure in biomedical research.
Latest Patents
Helene holds a patent for her groundbreaking work titled "Pathology biomarker assay." This patent involves methods for diagnosing or quantifying pathological conditions through an advanced immunoassay. The method measures neo-epitope containing protein fragments present in biofluid samples. By associating the elevated levels of these measures in patients with the presence or extent of pathology, her research offers valuable insights into disease detection. Her immunoassay technique involves the interaction of protein fragments with immunological binding partners, specifically targeting neo-epitopes generated by protein cleavage. This innovative approach includes neo-epitopes derived from various proteins such as collagen types I, III, IV, V, VI, elastin, and others, enhancing the reliability of diagnostics.
Career Highlights
Helene is a key member of Nordic Bioscience A/S, a company that focuses on advancing biomarker discovery and development. Her work in this organization is underscored by her patent and the ongoing research into effective diagnostic methods that could revolutionize the healthcare industry. Helene’s dedication to her field is characterized by her meticulous approach and commitment to innovation.
Collaborations
Collaboration plays a vital role in Helene's career, and she has worked alongside esteemed colleagues like Sanne S. Veidal and Morten A. Karsdal. Their joint efforts contribute to the development of innovative solutions in the realm of biomarker assays, reflecting the collaborative spirit that drives advancements in medical diagnostics.
Conclusion
Helene Skjøt-Arkil continues to push the boundaries of what is possible in pathology diagnostics through her inventive capabilities. Her patent and contributions to Nordic Bioscience A/S exemplify her commitment to improving patient outcomes. As a trailblazer in her field, Helene’s work not only enhances diagnostic processes but also inspires future innovations in biomedical research.